Department of Kidney Transplant, Hospital of Nephrology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Cell Transplant. 2020 Jan-Dec;29:963689720946663. doi: 10.1177/0963689720946663.
Renal ischemia/reperfusion (I/R) injury is a particular threat faced by clinicians in kidney transplantation. Previous studies have confirmed the importance of oxidative stress and inflammation in the pathogenesis of I/R injury. Angiopoietin-like protein 2 (ANGPTL2) belongs to the angiopoietin-like family and has been found to be involved in the regulation of kidney function as well as oxidative and inflammatory response. In the present study, we aimed to evaluate the role of ANGPTL2 in renal I/R injury . The human proximal tubular epithelial cell line (HK-2 cells) was subjected to hypoxia/ reoxygenation (H/R) to mimic I/R injury . We found that the expression level of ANGPTL2 was markedly increased in H/R-induced HK-2 cells. Knockdown of ANGPTL2 improved the decreased cell viability of HK-2 cells in response to H/R stimulation. Knockdown of ANGPTL2 significantly inhibited the H/R-caused increase in levels of reactive oxygen species, malondialdehyde, and proinflammatory cytokines, including interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha, as well as a decrease in superoxide dismutase activity in the HK-2 cells. Besides, the increased bax expression and caspase-3 activity and decreased bcl-2 expression in H/R-induced HK-2 cells were also attenuated by knockdown of ANGPTL2. Moreover, ANGPTL2 overexpression showed the opposite effects. Further mechanism investigations proved that the activation of Nrf2/HO-1 signaling pathway and the inhibition of toll-like receptor 4/nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway were both implicated in the renal-protective effects of ANGPTL2 knockdown on H/R-induced HK-2 cells. Collectively, these findings suggested that ANGPTL2 might be a new possible target for the treatment and prevention of renal I/R injury.
肾缺血/再灌注 (I/R) 损伤是肾移植临床医生面临的一个特殊威胁。先前的研究已经证实氧化应激和炎症在 I/R 损伤发病机制中的重要性。血管生成素样蛋白 2 (ANGPTL2) 属于血管生成素样家族,已被发现参与调节肾功能以及氧化和炎症反应。在本研究中,我们旨在评估 ANGPTL2 在肾 I/R 损伤中的作用。使用人近端肾小管上皮细胞系 (HK-2 细胞) 进行缺氧/复氧 (H/R) 以模拟 I/R 损伤。我们发现,ANGPTL2 的表达水平在 H/R 诱导的 HK-2 细胞中明显增加。ANGPTL2 敲低可改善 HK-2 细胞对 H/R 刺激的细胞活力下降。ANGPTL2 敲低显著抑制 H/R 引起的活性氧、丙二醛和促炎细胞因子(包括白细胞介素 (IL)-6、IL-1β 和肿瘤坏死因子-α)水平升高,以及 HK-2 细胞中超氧化物歧化酶活性降低。此外,ANGPTL2 敲低还减弱了 H/R 诱导的 HK-2 细胞中 bax 表达增加和 caspase-3 活性增加以及 bcl-2 表达减少。此外,ANGPTL2 过表达表现出相反的效果。进一步的机制研究证明,Nrf2/HO-1 信号通路的激活和 Toll 样受体 4/核因子 kappa-轻链增强子的 B 细胞信号通路的抑制都参与了 ANGPTL2 敲低对 H/R 诱导的 HK-2 细胞的肾保护作用。综上所述,这些发现表明 ANGPTL2 可能是治疗和预防肾 I/R 损伤的一个新的潜在靶点。